Minimally Invasive Vascular Occlusion Device for PDA Cleared in Europe
February 11, 2008 – A new minimally invasive vascular occlusion device designed to close a patent ductus arteriosus (PDA) received European CE Mark approval.
AGA Medical Corp. (AGA) announced today it received approval for the AMPLATZER Duct Occluder II (ADO II), a self-expanding nitinol mesh device designed to occlude or close PDA, a type of congenital heart defect that occurs when a blood vessel called the ductus arteriosus fails to close after birth.
The device has two retention disks positioned on either side of the duct and connected by a waist. The ADO II is designed with a screw mechanism for attachment to the deployment cable that allows the device to be withdrawn and repositioned, if necessary, prior to release from the cable.
For more information: www.amplatzer.com
More like this
- Minimally Invasive Vascular Occlusion Device for PDA Cleared in Europe
- New Heart Assist Pump Allows Minimally Invasive Approach at Vanderbilt Heart and Vascular Institute
- Most Innovative Heart Centers: Methodist DeBakey Heart and Vascular Center
- FDA Clears Watchman Device as an Alternative to Anticoagulation Therapy
- Pathway’s Jetstream G2 System Cleared for Minimally Invasive Treatment of PAD